ConverGene Announces Sponsored Research Agreement with MD Anderson CAMBRIDGE, Md., Sept. 18, 2017 (GLOBE NEWSWIRE) -- ConverGene is pleased to announce that it has entered into a collaboration with The University of Texas MD Anderson Cancer Center (“MD Anderson”)...

ConverGene Announces Sponsored Research Agreement with University of Maryland, Baltimore to Evaluate First-in-class Anti-cancer Agents CAMBRIDGE, Md., Jan. 25, 2017 (GLOBE NEWSWIRE) -- ConverGene has entered into a Sponsored Research Agreement with University of Maryland, Baltimore. Under this agreement University of Maryland...

ConverGene Announces a License Agreement With the National Center for Advancing Translational Sciences CAMBRIDGE, Md., Dec. 13, 2016 (GLOBE NEWSWIRE) -- ConverGene has entered into an exclusive license agreement with the National Center for Advancing Translational Sciences (NCATS), part of the...